Thank you Mark when we dipped into the Viridian Cannabis Deal Tracker to prepare this weeks Insightsbof the Week it was very exciting to uncover the increase in capital investment in the industry. Let’s hope this trend continues.
I help Cannabis and Psychedelic companies reach key decision-makers and investors at scale—through Highly Capitalized Network + LinkedIn.
Latest reporting from Viridian Capital Advisors shows Cannabis #investors are back. So far this year, Cannabis #capitalraises have reached $1.6 billion, marking a 14.4% increase compared to the same timeframe in 2023. The average deal size has #surged by almost 35% in the current year-to-date period compared to last year. Globally, the share of debt in total capital raised has decreased from 68.6% to 51.2%. However, the U.S. has diverged from this trend, with 72.7% of its capital raised through #debt, up from 41.4% in 2023. In the U.S., capital raises now make up 62.1% of the total, a rise from 52.3% at the same point last year. Meanwhile, capital raises from regions #outside Canada and the U.S. have reached a historic high of 6.1% of the total funds raised. #Public companies have captured 74.7% of the year-to-date capital raises, the highest share since 2021. Paradoxically, there's never been a better time to invest in #Cannabis
